Enflurane Hepatotoxicity
A Clinicopathologic Study of 24 Cases
- JAMES H. LEWIS, M.D.;
- HYMAN J. ZIMMERMAN, M.D.;
- KAMAL G. ISHAK, M.D.; and
- FLORABEL G. MULLICK, M.D.
Abstract
Analysis of 24 cases of enflurane anesthesia-associated hepatic injury shows that the clinical, biochemical, and histologic features are similar to those seen with halothane- and methoxyflurane-related hepatitis. Postoperative fever was the presenting symptom in 19 patients. Jaundice occurred in 19 patients after a mean latent period of 8 days. Sixteen patients had been previously exposed to enflurane or halothane, and the latent period from exposure to the onset of symptoms or jaundice was shortened in these patients. There were five fatalities among the entire group. Liver biopsy most characteristically showed centrilobular necrosis, occasionally with ballooning degeneration and fatty change. The presumed mechanism of injury is metabolic idiosyncracy, and prior exposure to a haloalkane anesthetic may increase the risk of hepatic injury after enflurane administration.
Article and Author Information
-
▸From the Department of Medicine, Division of Gastroenterology and D.C. Registry of Drug-Induced Liver Disease, George Washington University Medical Center; and the Departments of Hepatic Pathology and Environmental and Drug-Induced Pathology, Armed Forces Institute of Pathology; Washington, D.C.
-
▸Requests for reprints should be addressed to Hyman J. Zimmerman, M.D.; Chief, Division of Gastroenterology, 2150 Pennsylvania Avenue, N.W.; Washington, D.C. 20037.
- © 1983 American College of Physicians
RSS Feeds









